Helpdesk

Sales contact

Home > Oncology

Oncology

Article

Direct insights from cancer patients: How they help us understand disease burden and the need for an individualized approach

Cultural differences and individual preferences have a significant impact on healthcare and clinical trial experience. Solutions exist in attempt to reduce these disparities, but often rely solely on healthcare providers...

Article

Mitigating the risks of long-term oncology eCOA clinical trials

Oncology

Long study duration can have a negative impact on patient compliance As for any clinical trial, poor compliance in oncology...

Article

Addressing the specific complexities of oncology eCOA clinical trials

Oncology

The oncology research pathway is paved with numerous challenges, and oncology clinical trials have one of the lowest success rates....

Case study

Oncology Case Study

Oncology

Oncology studies present specific challenges that generate complex eCOA build and management: complex study design, frequent amendments, and long study...

Article

eCOA solutions in oncology: how to avoid common pitfalls and ensure the success of long-term studies?

Oncology

Among numerous clinical study procedures, capturing patients reported outcomes can bring its own set of challenges and, if not well...

White Paper

eCOA challenges of long term studies #whitepaper

Oncology Project management

How to anticipate eCOA complexities in multi-year studies & develop best practice to support sites? Using eCOA solutions can bring...

Subscribe to our newsletter

Rare disease clinical research: it is time to tackle what...

The client’s voice: why they consistently choose Kayentis

Why you should join Kayentis

Rethinking pediatric clinical trials: guidelines from pediatric experts

Overcoming challenges in long-lasting pediatric clinical trials – Insights from...

Tackling the specificities of NASH/MASH clinical trials

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA